Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SNWV Sanuwave Health Inc
- Stocks
- Healthcare
- NASDAQ: SNWV
Price (delayed)
$27
Market cap
$231M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.51
Enterprise value
$249.37M
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally.
Highlights
The gross profit has soared by 73% year-on-year and by 13% since the previous quarter
SNWV's revenue has soared by 62% YoY and by 11% QoQ
The equity has surged by 64% year-on-year but it has declined by 36% since the previous quarter
Sanuwave Health's EPS has decreased by 41% YoY but it has increased by 36% QoQ
The net income has dropped by 88% year-on-year and by 3.7% since the previous quarter
The quick ratio has declined by 19% since the previous quarter
Key stats
What are the main financial stats of SNWV
Market
Valuations
Earnings
Shares outstanding
8.56M
Market cap
$231M
Enterprise value
$249.37M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
6.38
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.89
Revenue
$36.19M
Gross profit
$27.73M
Operating income
$7.45M
Net income
-$32.52M
EBIT
-$20.56M
EBITDA
-$19.36M
Free cash flow
-$700,000
Per share
Balance sheet
Liquidity
EPS
-$4.51
EPS diluted
-$8.26
Free cash flow per share
-$0.08
Book value per share
-$2.02
Revenue per share
$4.23
TBVPS
$2.34
Total assets
$30.86M
Total liabilities
$48.15M
Debt
$26.87M
Equity
-$17.29M
Working capital
-$28.44M
Debt to equity
-1.55
Current ratio
0.4
Quick ratio
0.26
Net debt/EBITDA
-0.95
Margins
Efficiency
Dividend
EBITDA margin
-53.5%
Gross margin
76.6%
Net margin
-89.9%
Operating margin
20.6%
Return on assets
-125.3%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
-56.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SNWV stock price
How has the Sanuwave Health stock price performed over time
Intraday
-4.66%
1 week
-2.24%
1 month
-12.62%
1 year
N/A
YTD
N/A
QTD
-23.66%
Financial performance
How have Sanuwave Health's revenue and profit performed over time
Revenue
$36.19M
Gross profit
$27.73M
Operating income
$7.45M
Net income
-$32.52M
Gross margin
76.6%
Net margin
-89.9%
The net income has dropped by 88% year-on-year and by 3.7% since the previous quarter
The gross profit has soared by 73% year-on-year and by 13% since the previous quarter
SNWV's revenue has soared by 62% YoY and by 11% QoQ
The operating income has grown by 38% from the previous quarter
Price vs fundamentals
How does SNWV's price correlate with its fundamentals
Growth
What is Sanuwave Health's growth rate over time
Valuation
What is Sanuwave Health stock price valuation
P/E
N/A
P/B
N/A
P/S
6.38
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.89
Sanuwave Health's EPS has decreased by 41% YoY but it has increased by 36% QoQ
The equity has surged by 64% year-on-year but it has declined by 36% since the previous quarter
SNWV's revenue has soared by 62% YoY and by 11% QoQ
Efficiency
How efficient is Sanuwave Health business performance
SNWV's return on assets has dropped by 55% year-on-year but it is up by 3.8% since the previous quarter
Sanuwave Health's return on sales has decreased by 4.6% QoQ
Dividends
What is SNWV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SNWV.
Financial health
How did Sanuwave Health financials performed over time
Sanuwave Health's total assets is 36% lower than its total liabilities
The current ratio has soared by 167% YoY but it has contracted by 7% from the previous quarter
Sanuwave Health's total liabilities has decreased by 32% YoY but it has increased by 12% from the previous quarter
The debt to equity has shrunk by 138% YoY but it is up by 24% QoQ
The equity has surged by 64% year-on-year but it has declined by 36% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.